Primemd Inc.

Primemd Inc.

PRMD
Primemd Inc.US flagOther OTC
0.00
USD
- -
- -
20,349.00Market Cap
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
TTM
Revenue per Share
0.02
- -
- -
0.06
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.02
Basic EPS, GAAP
-0.05
0.62
-0.01
-0.02
-0.03
-0.27
-0.05
-0.05
-0.05
0.06
-0.03
-0.03
Free Cash Flow per Basic Share
-0.05
-0.03
-0.01
-0.01
-0.02
-0.04
-0.05
-0.05
-0.04
-0.05
-0.03
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.23
0.85
0.84
0.82
0.8
0.52
0.47
0.42
0.37
0.43
-1.76
-1.78
Tangible Book Value per Share
0.23
0.85
0.79
0.81
0.58
0.52
0.49
0.44
0.38
0.45
0.4
0.37
Basic Weighted Avg Shares
3
3
3
3
3
3
3
3
3
3
3
3
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-219.6
-19,999,900
-20,875,800
-129.85
-183.7
-249.51
-301.17
-508.82
-313.85
-439.77
-158.38
-57.55
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
2
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-219.6
190,000,000
-1,974,000
-29.85
-110.91
-1,447.11
-255.07
-407.34
-295.44
396.19
-149.14
-117.12
Working Capital
1
3
2
2
1
1
1
1
1
1
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
3
2
2
2
2
2
1
1
1
1
1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
115.28
-0.76
-2.02
-3.24
-41.6
-9.65
-11.57
-12.75
15.71
- -
-16.5

Capital Structure

FRC

in mil. unless spec.
Jun'09
Sep'09
Dec'09
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Jun'09
Sep'09
Dec'09
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.76%
-4.71%
-10.18%
Free Cash Flow
8.24%
-4.09%
-44.03%
Net Income, GAAP
-64.77%
-90.83%
-151.93%
Sales/Revenue/Turnover
- -
6.57%
37.96%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
-0.02
-0.01
-0.01
- -
0.06
2008
- -
-0.02
-0.01
- -
-0.03
2009
-0.01
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Raymond N. Joeckel
Full Time Employees
1
Sector
Healthcare
Industry
Medical - Care Facilities
Address
93 Spyglass Drive Littleton CO United States of America 80123
IPO Date
Apr 5, 1994
Business
Primemd Inc. (PRMD) engages in the purchase, development, and management of residential and commercial real estate properties in the United States; it also holds interests in oil and gas properties. The company offers real estate acquisition, property development services, construction management, leasing, and ownership of select energy assets including mineral rights and producing wells. Headquartered at 93 Spyglass Drive in Littleton, Colorado, Primemd Inc. was founded on October 12, 1979, originally as Eagle Exploration Co., and changed its name to Primemd Inc. in June 2021 to reflect its strategic pivot toward diversified real estate and energy holdings. The company primarily targets domestic real estate markets with a focus on value-add opportunities in residential subdivisions and commercial spaces, alongside opportunistic energy investments. In recent developments, Primemd Inc. has maintained a low-profile operational strategy post its 2021 rebranding, with no major publicly reported acquisitions, funding rounds, partnerships, or product expansions noted in the last 1-2 years as of late 2025. It operates as a standalone entity listed on OTCPK with a minimal market capitalization, emphasizing long-term asset holding over aggressive growth initiatives.